ALFA FinderBSE filing, NSE: PANYAMCEM. Summary written from the filing by ALFA Finder's alert engine.
Panyam Cements & Mineral Industries Ltd: key numbers
- Share price
- ₹96.99
- Market cap
- ₹77.80 Cr
- Revenue (annual)
- ₹84.88 Cr
- Net profit (annual)
- ₹-38.24 Cr
- P/E (TTM)
- -1.8×Sector 33.5×
- Promoter holding
- 95.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Panyam Cements & Mineral Industries Ltd
All →Panyam Cements & Mineral Industries Other Announcement
Panyam Cements filed its periodic report on physical share re-lodgement under the SEBI special window. All figures for September 2026 are NIL, indicating no transfer requests were received or processed.
Panyam Cements & Mineral Industries Annual General Meeting
Panyam Cements held its 70th Annual General Meeting on September 30, 2026, where shareholders adopted the financial statements and approved the re-appointment of a director.
Panyam Cements & Mineral Industries Management Change
Panyam Cements & Mineral Industries Limited appointed Mr. Sunki Reddy Pitchi Reddy as Chief Financial Officer. The appointment is effective from June 29, 2026.
Panyam Cements & Mineral Industries Q1 FY27 Results: Net Loss of ₹23 Cr, Loss Widens
Panyam Cements & Mineral Industries Ltd reported revenue from operations of ₹35.3 Cr (+11666.7% YoY) and a net loss of ₹23 Cr for Q1 FY27.
- Key figure
- Net loss ₹23 Cr
Panyam Cements & Mineral Industries Board Meeting Date
Panyam Cements announced a board meeting on 29th September 2026 to consider and approve the unaudited financial results for the quarter ended 30th June 2026.
Panyam Cements & Mineral Industries Annual Report
Panyam Cements & Mineral Industries Ltd has submitted its Annual Report for the Financial Year 2025-26, which includes the notice for its 70th Annual General Meeting.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr